Please login to the form below

Not currently logged in
Email:
Password:

granulomatosis

This page shows the latest granulomatosis news and features for those working in and with pharma, biotech and healthcare.

Nucala works in rare inflammatory disease, says GSK

Nucala works in rare inflammatory disease, says GSK

lungs. GSK is planning to file for approval of Nucala in HES next year, hoping to add to its currently-approved use in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis

Latest news

  • CHMP backs Sanofi’s all-oral sleeping sickness drug CHMP backs Sanofi’s all-oral sleeping sickness drug

    remission with minimal residual disease greater than or equal to 0.1%, and also backed Roche’s MabThera (rituximab) for adults with severe, active granulomatosis with polyangiitis and microscopic polyangiitis in

  • Roche’s MabThera ends drug drought for serious skin disease Roche’s MabThera ends drug drought for serious skin disease

    Rituximab already has a long list of approved indications – including autoimmune disease rheumatoid arthritis, granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA) – and despite being on the market for more than

  • GSK gets another approval for Nucala in US GSK gets another approval for Nucala in US

    The US regulator gave the go-ahead yesterday to use Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that causes vasculitis, inflammation in

  • GSK preps COPD filing for asthma pioneer Nucala GSK preps COPD filing for asthma pioneer Nucala

    with eosinophilic granulomatosis with polyangiitis (EGPA), a rare disorder characterised by widespread inflammation in the walls of small blood vessels.  It has also started trials of the drug in severe nasal

  • GSK starts trial of Nucala to seek alternate indications GSK starts trial of Nucala to seek alternate indications

    levels of eosinophil white cells - including chronic obstructive pulmonary disease (COPD), severe atopic dermatitis, hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis.

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

How Far Do You Want To Go?
Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…...
"Fishbowl" Web Meeting for Internal POA Discussions: a Customer Story
Learn how our client successfully carried out a set of three virtual plan of action (POA) discussions, including one internal “Fishbowl” web meeting....
Whats the difference between patient engagement and patient experience?
We all talk a lot about patient engagement and patient experience. And sometimes, these terms are used interchangeably across the industry. But while they’re both important, they’re not the same....

Infographics